Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M147Revenue (TTM) $M59.6Net Margin (%)-119.6Altman Z-Score-41.2
Enterprise Value $M-38.9EPS (TTM) $-2.7Operating Margin %-117.2Piotroski F-Score5
P/E(ttm)--Beneish M-Score-0.3Pre-tax Margin (%)-121.5Higher ROA y-yY
Price/Book3.510-y EBITDA Growth Rate %-55.8Quick Ratio1.4Cash flow > EarningsN
Price/Sales0.95-y EBITDA Growth Rate %-29.2Current Ratio1.5Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-70.6Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-250.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M28.2ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with CTIC

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

CTIC is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


CTIC: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BIANCO JAMES APresident and CEO 2016-06-24Sell1,000$3.740.27view
BIANCO JAMES APresident and CEO 2016-05-27Sell1,000$4.515.33view
BIANCO JAMES APresident and CEO 2016-04-29Sell1,000$5.2-0.19view
BIANCO JAMES APresident and CEO 2016-03-28Sell1,000$4.95.92view
BIANCO JAMES APresident and CEO 2016-03-21Sell31,817$5.5-5.64view
Plunkett MatthewEVP, Chief Business Officer 2016-03-04Sell1,000$5.9-12.03view
BIANCO JAMES APresident and CEO 2016-02-26Sell1,000$6.3-17.62view
SINGER JACK WEVP, Chief Scientific Officer 2016-02-26Sell1,500$6.3-17.62view
BIANCO JAMES APresident and CEO 2016-02-16Sell10,000$4.223.57view
Plunkett MatthewEVP, Chief Business Officer 2016-02-04Sell1,000$11.5-54.87view

Press Releases about CTIC :

Quarterly/Annual Reports about CTIC:

News about CTIC:

Articles On GuruFocus.com
Monday Morning Pre-Market Insights: Celldex Therapeutics, Celladon Corp, CTI BioPharma Corp, TG Ther Jun 01 2015 
Weekly CEO Sells Highlight: Groupon Inc., Cell Therapeutics Inc., Standard Pacific Corp and Dollar G Mar 24 2014 
These 4 Biotech Stocks Are a Buy Now Feb 08 2012 
Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 50,000 Shares Feb 25 2011 
Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 50,000 Shares Jan 28 2011 
Weekly CEO Sells Highlight: CTIC, DDR, UNM, BRCM, TC Jan 09 2011 
Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 250,000 Shares Jan 03 2011 
Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 200,000 Shares Dec 17 2010 
Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 150,000 Shares Dec 10 2010 
Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 100,000 Shares Nov 05 2010 

More From Other Websites
CTI BIOPHARMA CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Jan 24 2017
CTI BioPharma Appoints Leading BioPharma Executive Michael Metzger To Board Of Directors Jan 24 2017
6:11 pm CTI BioPharma regained compliance with Nasdaq Listing Rule for minimum bid price; matter is... Jan 22 2017
CTI BIOPHARMA CORP Files SEC form 8-K, Other Events Jan 20 2017
Latest Reports on Recent Market Movers: 3D Systems and CTI BioPharma Jan 10 2017
CTI BIOPHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... Jan 09 2017
CTI BioPharma Announces Progress Of Lead Programs And Strategic Objectives For 2017 Jan 09 2017
CTI Biopharma stock revived after FDA ruling, reverse stock split Jan 06 2017
CTI BIOPHARMA CORP Files SEC form 8-K, Material Modification to Rights of Security Holders Jan 05 2017
CTI BioPharma Announces Removal Of Full Clinical Hold On Pacritinib Jan 05 2017
ETFs with exposure to CTI BioPharma Corp. : January 4, 2017 Jan 04 2017
CTI BioPharma Corp. breached its 50 day moving average in a Bullish Manner : CTIC-US : January 4,... Jan 04 2017
CTI BIOPHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... Dec 23 2016
CTI BIOPHARMA CORP Files SEC form 8-K, Material Modification to Rights of Security Holders Dec 21 2016
ETFs with exposure to CTI BioPharma Corp. : December 13, 2016 Dec 13 2016
Do Hedge Funds Love Manning and Napier Inc (MN)? Dec 11 2016
CTI BIOPHARMA CORP Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements... Dec 09 2016
PERSIST-2 Phase 3 Study Of Pacritinib Versus Best Available Therapy Shows Encouraging Clinical... Dec 06 2016
ETFs with exposure to CTI BioPharma Corp. : December 2, 2016 Dec 02 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)